See what questions
a doctor would ask.
A gene company therapy has developed a drug called Advexin which, when used with chemotherapy prior to surgery, causes tumors to shrink by at least 50%. This potentially makes the surgery less invasive and more effective. Early trial results indicate that it is very successful. Patients with advanced breast cancer are particularly benefited by this tumor reduction therapy.
Source: summary of medical news story as reported by Reuters Health
About: New Advexin tumor shrinking drug developed
Date: 9 December 2004
Source: Reuters Health
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City